Literature DB >> 28893420

The hallmarks of mitochondrial dysfunction in chronic kidney disease.

Daniel L Galvan1, Nathanael H Green2, Farhad R Danesh3.   

Abstract

Recent advances have led to a greater appreciation of how mitochondrial dysfunction contributes to diverse acute and chronic pathologies. Indeed, mitochondria have received increasing attention as a therapeutic target in a variety of diseases because they serve as key regulatory hubs uniquely situated at crossroads between multiple cellular processes. This review provides an overview of the role of mitochondrial dysfunction in chronic kidney disease, with special emphasis on its role in the development of diabetic nephropathy. We examine the current understanding of the molecular mechanisms that cause mitochondrial dysfunction in the kidney and describe the impact of mitochondrial damage on kidney function. The new concept that mitochondrial shape and structure are closely linked with its function in the kidneys is discussed. Furthermore, the mechanisms that translate cellular cues and demands into mitochondrial remodeling and cellular damage, including the role of microRNAs and long noncoding RNAs, are examined with the final goal of identifying mitochondrial targets to improve treatment of patients with chronic kidney diseases.
Copyright © 2017 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  acute kidney injury; chronic kidney disease; diabetes; diabetic nephropathy; mitochondria; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28893420      PMCID: PMC5667560          DOI: 10.1016/j.kint.2017.05.034

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  40 in total

1.  Activation of peroxisome proliferator-activated receptor-γ coactivator 1α ameliorates mitochondrial dysfunction and protects podocytes from aldosterone-induced injury.

Authors:  Yanggang Yuan; Songming Huang; Wenyan Wang; Yingying Wang; Ping Zhang; Chunhua Zhu; Guixia Ding; Bicheng Liu; Tianxin Yang; Aihua Zhang
Journal:  Kidney Int       Date:  2012-05-30       Impact factor: 10.612

Review 2.  Transcriptional paradigms in mammalian mitochondrial biogenesis and function.

Authors:  Richard C Scarpulla
Journal:  Physiol Rev       Date:  2008-04       Impact factor: 37.312

Review 3.  MicroRNAs and their applications in kidney diseases.

Authors:  Shawn S Badal; Farhad R Danesh
Journal:  Pediatr Nephrol       Date:  2014-06-14       Impact factor: 3.714

4.  Targeting mitochondrial oxidants may facilitate recovery of renal function during infant sepsis.

Authors:  C R Sims; L A MacMillan-Crow; P R Mayeux
Journal:  Clin Pharmacol Ther       Date:  2014-08-22       Impact factor: 6.875

Review 5.  Renal substrate metabolism.

Authors:  G Wirthensohn; W G Guder
Journal:  Physiol Rev       Date:  1986-04       Impact factor: 37.312

6.  EGF receptor deletion in podocytes attenuates diabetic nephropathy.

Authors:  Jianchun Chen; Jian-Kang Chen; Raymond C Harris
Journal:  J Am Soc Nephrol       Date:  2014-09-03       Impact factor: 10.121

7.  Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice.

Authors:  Björn Hartleben; Markus Gödel; Catherine Meyer-Schwesinger; Shuya Liu; Theresa Ulrich; Sven Köbler; Thorsten Wiech; Florian Grahammer; Sebastian J Arnold; Maja T Lindenmeyer; Clemens D Cohen; Hermann Pavenstädt; Dontscho Kerjaschki; Noboru Mizushima; Andrey S Shaw; Gerd Walz; Tobias B Huber
Journal:  J Clin Invest       Date:  2010-04       Impact factor: 14.808

8.  Mitochondrial fission triggered by hyperglycemia is mediated by ROCK1 activation in podocytes and endothelial cells.

Authors:  Wenjian Wang; Yin Wang; Jianyin Long; Jinrong Wang; Sandra B Haudek; Paul Overbeek; Benny H J Chang; Paul T Schumacker; Farhad R Danesh
Journal:  Cell Metab       Date:  2012-02-08       Impact factor: 27.287

Review 9.  Metabolic signaling functions of ER-mitochondria contact sites: role in metabolic diseases.

Authors:  Emily Tubbs; Jennifer Rieusset
Journal:  J Mol Endocrinol       Date:  2016-12-13       Impact factor: 5.098

Review 10.  Peroxisome proliferator activating receptor-γ and the podocyte.

Authors:  Caroline Platt; Richard J Coward
Journal:  Nephrol Dial Transplant       Date:  2017-03-01       Impact factor: 5.992

View more
  112 in total

1.  Protective effect of cinnamon against acetaminophen-mediated cellular damage and apoptosis in renal tissue.

Authors:  Ahmed Abdeen; Afaf Abdelkader; Mohamed Abdo; Gamal Wareth; Mohamed Aboubakr; Lotfi Aleya; Mohamed Abdel-Daim
Journal:  Environ Sci Pollut Res Int       Date:  2018-11-03       Impact factor: 4.223

2.  C3a receptor blockade protects podocytes from injury in diabetic nephropathy.

Authors:  Marina Morigi; Luca Perico; Daniela Corna; Monica Locatelli; Paola Cassis; Claudia Elisa Carminati; Silvia Bolognini; Carlamaria Zoja; Giuseppe Remuzzi; Ariela Benigni; Simona Buelli
Journal:  JCI Insight       Date:  2020-03-12

Review 3.  Mechanisms of Synergistic Interactions of Diabetes and Hypertension in Chronic Kidney Disease: Role of Mitochondrial Dysfunction and ER Stress.

Authors:  Zhen Wang; Jussara M do Carmo; Alexandre A da Silva; Yiling Fu; John E Hall
Journal:  Curr Hypertens Rep       Date:  2020-02-03       Impact factor: 5.369

Review 4.  Food as medicine: targeting the uraemic phenotype in chronic kidney disease.

Authors:  Denise Mafra; Natalia A Borges; Bengt Lindholm; Paul G Shiels; Pieter Evenepoel; Peter Stenvinkel
Journal:  Nat Rev Nephrol       Date:  2020-09-22       Impact factor: 28.314

5.  Targeting a Braf/Mapk pathway rescues podocyte lipid peroxidation in CoQ-deficiency kidney disease.

Authors:  Eriene-Heidi Sidhom; Choah Kim; Maria Kost-Alimova; May Theng Ting; Keith Keller; Julian Avila-Pacheco; Andrew Jb Watts; Katherine A Vernon; Jamie L Marshall; Estefanía Reyes-Bricio; Matthew Racette; Nicolas Wieder; Giulio Kleiner; Elizabeth J Grinkevich; Fei Chen; Astrid Weins; Clary B Clish; Jillian L Shaw; Catarina M Quinzii; Anna Greka
Journal:  J Clin Invest       Date:  2021-03-01       Impact factor: 14.808

6.  Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS.

Authors:  Jinhua Li; Yu Bo Yang Sun; Weiyi Chen; Jinjin Fan; Songhui Li; Xinli Qu; Qikang Chen; Riling Chen; Dajian Zhu; Jinfeng Zhang; Zhuguo Wu; Honggang Chi; Simon Crawford; Viola Oorschot; Victor G Puelles; Peter G Kerr; Yi Ren; Susan K Nilsson; Mark Christian; Huanwen Tang; Wei Chen; John F Bertram; David J Nikolic-Paterson; Xueqing Yu
Journal:  EMBO Rep       Date:  2020-01-09       Impact factor: 8.807

7.  Visualizing mitochondrial (dys)function using positron emission tomography imaging.

Authors:  Anand Srivastava; Pottumarthi V Prasad
Journal:  Kidney Int       Date:  2020-07       Impact factor: 10.612

8.  Regulation of mitochondrial dynamics and energetics in the diabetic renal proximal tubule by the β2-adrenergic receptor agonist formoterol.

Authors:  Kristan H Cleveland; Frank C Brosius; Rick G Schnellmann
Journal:  Am J Physiol Renal Physiol       Date:  2020-09-21

9.  Changes in cell fate determine the regenerative and functional capacity of the developing kidney before and after release of obstruction.

Authors:  Vidya K Nagalakshmi; Minghong Li; Soham Shah; Joseph C Gigliotti; Alexander L Klibanov; Frederick H Epstein; Robert L Chevalier; R Ariel Gomez; Maria Luisa S Sequeira-Lopez
Journal:  Clin Sci (Lond)       Date:  2018-12-05       Impact factor: 6.124

Review 10.  Mitochondrial Metabolism in Acute Kidney Injury.

Authors:  Amanda J Clark; Samir M Parikh
Journal:  Semin Nephrol       Date:  2020-03       Impact factor: 5.299

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.